NCT03740165 · Interventional trial
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
Overall registry status Completed
Phase 3
Conditions Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms
Delaware Valley sites
- MD Anderson Cancer Center at Cooper ( Site 0067) · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory